The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

DolCas Biotech, a company known for its advancements in nutraceutical ingredients, has unveiled a novel approach to functional foods by incorporating marine collagen tripeptides into chocolate bars.

The new chocolate bar features Morikol, a highly concentrated fish collagen tripeptide that is clinically validated to deliver effective results at a minimal dose.

Each 8g square contains 1g of Morikol, a low-molecular weight collagen designed for high bioavailability and rapid absorption. This unique formulation allows for the integration of collagen into various chocolate types – milk, dark or white – while preserving their familiar flavour and texture.

KG Rao, founder and CEO of DolCas Biotech, highlighted the advantages of Morikol’s low dosage. "Most collagen ingredients come in 5g-10g doses. Morikol’s low concentration makes it ideal for innovative delivery formats," Rao commented. A single square of chocolate can provide a full clinical dose of collagen peptides, catering to consumers interested in beauty-from-within and joint health.

Clinical studies have demonstrated the effectiveness of Morikol. In a trial involving 53 women, participants consuming 1g of Morikol daily for 12 weeks reported significant improvements in skin elasticity and hydration, as well as a notable reduction in the appearance of wrinkles. Another study with 64 participants suffering from mild knee pain showed that a 2g daily dose of Morikol helped alleviate joint discomfort and reduce fluid accumulation.

The ingredient's formulation is designed to facilitate the direct uptake of its tripeptides through the intestinal barrier, enhancing its efficacy. Previous research has indicated that these tripeptides can stimulate collagen production, benefiting skin, bone and connective tissue integrity.

Morikol is positioned as a versatile ingredient suitable for a range of functional food applications. Its neutral flavour and odourless properties allow it to blend seamlessly into chocolate products, appealing to manufacturers looking to enhance their offerings with health benefits. The ingredient is also non-GMO, allergen-friendly, and certified kosher and halal, meeting various dietary requirements.

The ingredient presents a promising opportunity for chocolate manufacturers to innovate and cater to health-conscious consumers. The integration of such ingredients into traditional confections could redefine the chocolate category, aligning it with modern wellness trends.

DolCas Biotech, headquartered in New Jersey, specialises in developing clinically validated bioactive ingredients. With a focus on clean label products, the company aims to provide solutions that meet contemporary wellness needs while maintaining the integrity of natural ingredients.